DIN 02241837 — ESTALIS 250/50 MCG 50 MCG; 250 MCG
ESTALIS 250/50 MCG is a patch of Estradiol / Norethindrone Acetate marketed by SANDOZ CANADA INCORPORATED. The full Estradiol / Norethindrone Acetate monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02241837
- Brand name
- ESTALIS 250/50 MCG
- Active ingredient
- Estradiol / Norethindrone Acetate
- Strength
- 50 MCG; 250 MCG
- Dosage form
- PATCH
- Route
- TRANSDERMAL
- Manufacturer
- SANDOZ CANADA INCORPORATED
- Health Canada status
- MARKETED
- Drug class
- Combined estrogen-progestin hormone replacement therapy (transdermal)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Estradiol / Norethindrone Acetate products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02249405 | ACTIVELLE | 1 MG; 0.5 MG | TABLET | NOVO NORDISK CANADA INC | MARKETED |
| 02309009 | ACTIVELLE LD | 0.5 MG; 0.1 MG | TABLET | NOVO NORDISK CANADA INC | MARKETED |
| 02241835 | ESTALIS 140/50 MCG | 140 MCG; 50 MCG | PATCH | SANDOZ CANADA INCORPORATED | MARKETED |